Kane Biotech Inc.
KNBIF
$0.03
$0.006.40%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -75.07% | 70.33% | -9.75% | -56.50% | -107.35% |
| Total Depreciation and Amortization | -21.49% | 0.60% | -26.65% | 33.53% | -14.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 117.66% | -164.48% | -50.79% | 95.41% | 101.94% |
| Change in Net Operating Assets | 56.61% | -165.81% | -165.80% | 277.49% | 89.96% |
| Cash from Operations | 9.26% | 27.36% | -156.42% | 23.98% | 75.11% |
| Capital Expenditure | -- | -- | -200.00% | 13.51% | 50.67% |
| Sale of Property, Plant, and Equipment | 581.25% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 114.46% | -105.14% |
| Other Investing Activities | 88.58% | -65.44% | 17.18% | -107.33% | 195.08% |
| Cash from Investing | 233.90% | 5.45% | -238.05% | 464.52% | -100.09% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 81.10% | 26.83% | -0.26% | -0.26% | 97.50% |
| Issuance of Common Stock | -100.00% | -25.13% | 291.74% | 48.93% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 78.25% | -210.08% | 3.73% | 2.90% | 99.03% |
| Cash from Financing | -101.57% | 56.25% | 517.54% | 143.77% | 101.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -160.47% | 761.66% | 170.81% | 61.15% | 32.70% |